FibroGen, Inc (FGEN): Price and Financial Metrics

FGEN POWR Grades

• FGEN scores best on the Sentiment dimension, with a Sentiment rank ahead of 82.14% of US stocks.
• FGEN's strongest trending metric is Value; it's been moving down over the last 178 days.
• FGEN ranks lowest in Stability; there it ranks in the 6th percentile.

FGEN Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for FGEN is -6.56 -- better than merely 2.42% of US stocks.
• FGEN's price/sales ratio is 13.38; that's higher than the P/S ratio of 92.48% of US stocks.
• As for revenue growth, note that FGEN's revenue has grown -40.19% over the past 12 months; that beats the revenue growth of just 5.06% of US companies in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to FIBROGEN INC are WVE, ONCT, PLRX, FDMT, and CYCN.
• FGEN's SEC filings can be seen here. And to visit FIBROGEN INC's official web site, go to www.fibrogen.com.

FGEN Valuation Summary

• FGEN's price/sales ratio is 13.4; this is 605.26% higher than that of the median Healthcare stock.
• Over the past 102 months, FGEN's price/earnings ratio has gone up 27.9.

Below are key valuation metrics over time for FGEN.

FGEN Growth Metrics

The 2 year price growth rate now stands at -78.2%.
• The 4 year net cashflow from operations growth rate now stands at -5702.49%.
• Its 3 year cash and equivalents growth rate is now at 127.61%.

FGEN's revenue has moved down $134,204,000 over the prior 30 months.

The table below shows FGEN's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	122.911	-148.38	-361.557
2022-06-30	263.149	-52.245	-220.109
2022-03-31	257.707	-45.724	-281.473
2021-12-31	235.309	-82.232	-290.023
2021-12-31	235.309	-82.232	-290.023
2021-09-30	283.765	-34.5	-214.579

FGEN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• FGEN has a Quality Grade of B, ranking ahead of 75.49% of graded US stocks.
• FGEN's asset turnover comes in at 0.212 -- ranking 192nd of 681 Pharmaceutical Products stocks.
• CKPT, ARWR, and IBIO are the stocks whose asset turnover ratios are most correlated with FGEN.

The table below shows FGEN's key quality metrics over time.